Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78545752 | 7854575 | 2 | F | 2008 | 20110307 | 20110314 | 20160915 | EXP | US-JNJFOC-20110302764 | JANSSEN | 0.00 | A | M | Y | 0.00000 | 20160915 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78545752 | 7854575 | 1 | SS | DURAGESIC | FENTANYL | 1 | Transdermal | N | UNKNOWN | 0 | PATCH | ||||||||
| 78545752 | 7854575 | 2 | PS | DURAGESIC | FENTANYL | 1 | Transdermal | 10 YEARS AGO | N | UNKNOWN | 19813 | PATCH | |||||||
| 78545752 | 7854575 | 3 | SS | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | Y | N | UNKNOWN | 19813 | UNSPECIFIED | |||||||
| 78545752 | 7854575 | 4 | SS | DURAGESIC | FENTANYL | 1 | Transdermal | NDC 50458-0094-05 | N | 100958P1 | 19813 | MATRIX PATCH | |||||||
| 78545752 | 7854575 | 5 | SS | TYLOX | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | 5/500 MG AS NEEDED. | Y | N | 88790 | CAPSULES | |||||||
| 78545752 | 7854575 | 6 | SS | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | Y | 0 | TABLET | |||||||||
| 78545752 | 7854575 | 7 | C | SOMA | CARISOPRODOL | 1 | Oral | 0 | TABLET | ||||||||||
| 78545752 | 7854575 | 8 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 10/325 MG AS NEEDED | 0 | TABLET | |||||||||
| 78545752 | 7854575 | 9 | C | MORPHINE | MORPHINE | 1 | Oral | 0 | TABLET | ||||||||||
| 78545752 | 7854575 | 10 | C | LORTAB | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 0 | TABLET | ||||||||||
| 78545752 | 7854575 | 11 | C | GABAPENTINE | GABAPENTIN | 1 | Oral | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 78545752 | 7854575 | 1 | Back pain |
| 78545752 | 7854575 | 2 | Back pain |
| 78545752 | 7854575 | 3 | Back pain |
| 78545752 | 7854575 | 4 | Back pain |
| 78545752 | 7854575 | 5 | Breakthrough pain |
| 78545752 | 7854575 | 6 | Breakthrough pain |
| 78545752 | 7854575 | 7 | Muscle relaxant therapy |
| 78545752 | 7854575 | 8 | Breakthrough pain |
| 78545752 | 7854575 | 9 | Breakthrough pain |
| 78545752 | 7854575 | 10 | Breakthrough pain |
| 78545752 | 7854575 | 11 | Tremor |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 78545752 | 7854575 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 78545752 | 7854575 | Asthenia | |
| 78545752 | 7854575 | Breakthrough pain | |
| 78545752 | 7854575 | Drug effect decreased | |
| 78545752 | 7854575 | Emphysema | |
| 78545752 | 7854575 | Movement disorder | |
| 78545752 | 7854575 | Respiratory rate decreased | |
| 78545752 | 7854575 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 78545752 | 7854575 | 5 | 2010 | 2010 | 0 | |
| 78545752 | 7854575 | 6 | 2010 | 2010 | 0 | |
| 78545752 | 7854575 | 10 | 2008 | 0 |